Characteristics and Absolute Survival of Metastatic Colorectal Cancer Patients Treated With Biologics: A Real-World Data Analysis From Three European Countries
Introduction: Biologics were approved for the treatment of advanced colorectal cancer (CRC) based on favorable benefit-risk-assessments from randomized controlled trials (RCTs), but evidence on their use in the real-world setting is scarce. Based on descriptive analyses we therefore aimed to assess...
Main Authors: | Katja A. Oppelt, Josephina G. Kuiper, Ylenia Ingrasciotta, Valentina Ientile, Ron M. C. Herings, Michele Tari, Gianluca Trifirò, Ulrike Haug |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.630456/full |
Similar Items
-
Incidence of advanced colorectal cancer in Germany: comparing claims data and cancer registry data
by: Katja Anita Oppelt, et al.
Published: (2019-07-01) -
Are Patients with Psoriasis and Psoriatic Arthritis Undertreated? A Population-Based Study from Southern Italy
by: Ylenia Ingrasciotta, et al.
Published: (2021-07-01) -
IRINOTECAN, FLUOROURACIL AND LEUCOVORIN IN PATIENTS WITH METASTATIC COLORECTAL CANCER
by: Deyan Davidov
Published: (2008-09-01) -
OXALIPLATIN/5-FLUOROURACIL/LEUCOVORIN IN THE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER
by: Deyan N. Davidov
Published: (2013-12-01) -
Evaluating the recent developments in palliative chemotherapy for metastatic colorectal cancer
by: Sun Kyung Baek, et al.
Published: (2019-11-01)